Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act

Cancer

Volumn 121, Issue 14, 2015, Pages 2400-2410

  Dolecek, Therese A ^a   Dressler, Emily Van Meter ^b   Thakkar, Jigisha P ^c   Liu, Meng ^b   Al Qaisi, Abeer ^c   Villano, John L ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

benign tumor; incidence; malignant tumor; meningioma; prognosis; survival; treatment; trend

Indexed keywords

AFRICAN AMERICAN; AGE; CANCER REGISTRY; HEALTH SURVEY; HUMAN; INCIDENCE; LAW; LEGISLATION AND JURISPRUDENCE; MENINGEAL NEOPLASMS; MENINGIOMA; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; HUMANS; INCIDENCE; LEGISLATION AS TOPIC; MENINGEAL NEOPLASMS; MENINGIOMA; POPULATION SURVEILLANCE; REGISTRIES; SEER PROGRAM; UNITED STATES;

EID: 84934440521     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29379     Document Type: Article

References (36)

1. Benign Brain Tumor Cancer Registries Amendment Act, Public Law No. 107-260, 42 USC 280e.
2. Louis DN, Ohgaki H, Wiestler OD, et al., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114: 97-109.
3. Perry A, Stafford SL, Scheithauer BW, et al., Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997; 21: 1455-1465.
4. Ostrom QT, Gittleman H, Farah P, et al., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013; 15 (suppl 2): ii1-ii56.
5. Nakasu S, Hirano A, Shimura T, et al., Incidental meningiomas in autopsy study. Surg Neurol. 1987; 27: 319-322.
6. Kuratsu J, Kochi M, Ushio Y,. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg. 2000; 92: 766-770.
7. Vernooij MW, Ikram MA, Tanghe HL, et al., Incidental findings on brain MRI in the general population. N Engl J Med. 2007; 357: 1821-1828.
8. Yano S, Kuratsu J, Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg. 2006; 105: 538-543.
9. Sankila R, Kallio M, Jaaskelainen J, et al., Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland. Comparison of the observed and expected survival rates in a population-based series. Cancer. 1992; 70: 1568-1576.
10. Jaaskelainen J, Haltia M, Servo A,. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol. 1986; 25: 233-242.
11. Mirimanoff RO, Dosoretz DE, Linggood RM, et al., Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985; 62: 18-24.
12. Simpson D,. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20: 22-39.
13. Condra KS, Buatti JM, Mendenhall WM, et al., Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997; 39: 427-436.
14. Goldsmith BJ, Wara WM, Wilson CB, et al., Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994; 80: 195-201.
15. Norden AD, Drappatz J, Wen PY,. Advances in meningioma therapy. Curr Neurol Neurosci Rep. 2009; 9: 231-240.
16. Perry A, Scheithauer BW, Stafford SL, et al., "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999; 85: 2046-2056.
17. Wara WM, Sheline GE, Newman H, et al., Radiation therapy of meningiomas. Am J Roentgenol Radium Ther Nucl Med. 1975; 123: 453-458.
18. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
19. The North American Association of Central Cancer Registries (NAACCR). Race and Ethnicity Work Group. NAACCR Guideline for Enhancing Hispanic/Latino Identification: Revised NAACCR Hispanic/Latino Identification Algorithm (NHIA v2.2.1). Springfield, IL: NAACCR; September 2011.
20. Surveillance Research Program, National Cancer Institute. SEER Stat software, version 8.1.5 [software program]. Available at: www.seer.cancer.gov/seerstat. Accessed November 1, 2014.
21. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER Stat Database: Incidence-SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, November 2013 submission (2000-2011) -Linked to County Attributes-Total US, 1969-2012 Counties (released April 2014, updated May 7, 2014; based on the November 2013 submission). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch; 2014.
22. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 15: 547-569.
23. Kim HJ, Fay MP, Feuer EJ, et al., Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
24. National Cancer Institute. Joinpoint Regression Program, version 4.1.1 [software program]. Bethesda, MD: National Cancer Institute, DCCPS, Statistical Research and Applications Branch; 2014.
25. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). Research Data (1973-2011), released April 2014, based on the November 2013 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch; 2014.
26. IBM Corporation. IBM SPSS Statistics for Windows, version 21.0 [software package]. Armonk, NY: IBM Corporation; 2012.
27. Hosmer D, Lemeshow S, May S,. Applied Survival Analysis: Regression Modeling of Time to Event Data. 2nd ed. New York: John Wiley & Sons, Inc.; 2008.
28. McCarthy BJ, Kruchko C, Dolecek TA,. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends. J Registry Manag. 2013; 40: 32-35.
29. Barnholtz-Sloan JS, Kruchko C,. Meningiomas: causes and risk factors [serial online]. Neurosurg Focus. 2007; 23: E2.
30. Longstreth WT Jr, Dennis LK, McGuire VM, et al., Epidemiology of intracranial meningioma. Cancer. 1993; 72: 639-648.
31. Preston-Martin S, Mack W, Henderson BE,. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res. 1989; 49: 6137-6143.
32. Larjavaara S, Haapasalo H, Sankila R, et al., Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer. 2008; 99: 182-184.
33. Cahill KS, Claus EB,. Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article. J Neurosurg. 2011; 115: 259-267.
34. McCarthy BJ, Davis FG, Freels S, et al., Factors associated with survival in patients with meningioma. J Neurosurg. 1998; 88: 831-839.
35. Jaaskelainen J,. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol. 1986; 26: 461-469.
36. Santacroce A, Walier M, Regis J, et al., Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012; 70: 32-39.